UM

Browse/Search Results:  1-10 of 19 Help

Selected(0)Clear Items/Page:    Sort:
Are We Ready for a New Approach to Comparing Coverage and Reimbursement Policies for Medical Nutrition in Key Markets: An ISPOR Special Interest Group Report Journal article
Perugini, Moreno, Johnson, Tricia J., Beume, Tania Maria, Dong, Olivia M., Guerino, John, Hu, Hao, Kerr, Kirk, Kindilien, Shannon, Nuijten, Mark, Ofili, Theresa U., Taylor, Matthew, Wong, Alvin, Freijer, Karen. Are We Ready for a New Approach to Comparing Coverage and Reimbursement Policies for Medical Nutrition in Key Markets: An ISPOR Special Interest Group Report[J]. VALUE IN HEALTH, 2022, 25(5), 677-684.
Authors:  Perugini, Moreno;  Johnson, Tricia J.;  Beume, Tania Maria;  Dong, Olivia M.;  Guerino, John; et al.
Favorite | TC[WOS]:5 TC[Scopus]:4  IF:4.9/5.6 | Submit date:2022/06/10
Coverage  Food For Special Medical Purposes  Malnutrition  Medical Food  Medical Nutrition  Regional Differences  Reimbursement  
DG74 Drug utilization of patients with respiratory disease at community pharmacies in China: an analysis of chemical drugs (2014-2017) Journal article
Lai, Y., Chen, S., Chen, P., Chen, X., Ung, O. L. C., Hu, H.. DG74 Drug utilization of patients with respiratory disease at community pharmacies in China: an analysis of chemical drugs (2014-2017)[J]. Value in Health, 2019, S175-S175.
Authors:  Lai, Y.;  Chen, S.;  Chen, P.;  Chen, X.;  Ung, O. L. C.; et al.
Favorite | TC[WOS]:0   IF:4.9/5.6 | Submit date:2022/07/27
Community Pharmacy  Respiratory  
PRS48 Drug utilization of patients with respiratory disease at community pharmacies in China: an analysis of leading prescription and over-the-counter drugs Journal article
Lai, Y., Chen, X., Chen, S., Chen, P., Ung, O. L. C., Hu, H.. PRS48 Drug utilization of patients with respiratory disease at community pharmacies in China: an analysis of leading prescription and over-the-counter drugs[J]. Value in Health, 2019, S358-S358.
Authors:  Lai, Y.;  Chen, X.;  Chen, S.;  Chen, P.;  Ung, O. L. C.; et al.
Favorite | TC[WOS]:0   IF:4.9/5.6 | Submit date:2022/07/27
Drug Utilization  Respiratory  
PRS48 Drug utilization of patients with respiratory disease at community pharmacy in China: an analysis of leading prescription and over-the-counter drugs Conference paper
Lai, Y. F., Chen, X. W. , Chen, S. Q., Chen, P. H., Ung, O. L. C., Hu, H.. PRS48 Drug utilization of patients with respiratory disease at community pharmacy in China: an analysis of leading prescription and over-the-counter drugs[C], 2019, PRS48-PRS48.
Authors:  Lai, Y. F.;  Chen, X. W. ;  Chen, S. Q.;  Chen, P. H.;  Ung, O. L. C.; et al.
Favorite |  | Submit date:2022/07/27
Drug utilization  respiratory disease  
PDG74 Drug utilization of patients with respiratory disease at community pharmacies in China: an analysis of chemical drugs (2014-2017) Conference paper
Lai, Y. F., Chen, S. Q., Chen, P. H., Chen, X.W., Ung, O. L. C., Hu, H.. PDG74 Drug utilization of patients with respiratory disease at community pharmacies in China: an analysis of chemical drugs (2014-2017)[C], 2019, S175-S175.
Authors:  Lai, Y. F.;  Chen, S. Q.;  Chen, P. H.;  Chen, X.W.;  Ung, O. L. C.; et al.
Favorite |  | Submit date:2022/07/27
drug utilization  
PRS65 Effect and cost of traditional Chinese medicine Xiyanping injection for treating community acquired pneumonia among adults in China. Value in Health. 2019; 22: S175. Conference paper
Shi, H., Guo, W. J. , Zhu, H., Li, M., Ung, O. L. C., Hu, H., Han, S.. PRS65 Effect and cost of traditional Chinese medicine Xiyanping injection for treating community acquired pneumonia among adults in China. Value in Health. 2019; 22: S175.[C], 2019, S361-S361.
Authors:  Shi, H.;  Guo, W. J. ;  Zhu, H.;  Li, M.;  Ung, O. L. C.; et al.
Favorite |  | Submit date:2022/07/27
Xiyanping  traditional Chinese medicine  
DRUG UTILIZATION OF PATIENTS WITH RESPIRATORY DISEASE AT COMMUNITY PHARMACIES IN CHINA: AN ANALYSIS OF LEADING PRESCRIPTION AND OVER-THE-COUNTER DRUGS Journal article
Lai, YF, Chen, XW, Chen, SQ, Chen, PH, Ung, COL, Hu, H. DRUG UTILIZATION OF PATIENTS WITH RESPIRATORY DISEASE AT COMMUNITY PHARMACIES IN CHINA: AN ANALYSIS OF LEADING PRESCRIPTION AND OVER-THE-COUNTER DRUGS[J]. VALUE IN HEALTH, 2019, 22(2), S358-S358.
Authors:  Lai, YF;  Chen, XW;  Chen, SQ;  Chen, PH;  Ung, COL; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.9/5.6 | Submit date:2020/03/12
DRUG UTILIZATION OF PATIENTS WITH RESPIRATORY DISEASE AT COMMUNITY PHARMACIES IN CHINA: AN ANALYSIS OF CHEMICAL DRUGS Journal article
Lai, YF, Chen, SQ, Chen, PH, Chen, XW, Ung, COL, Hu, H. DRUG UTILIZATION OF PATIENTS WITH RESPIRATORY DISEASE AT COMMUNITY PHARMACIES IN CHINA: AN ANALYSIS OF CHEMICAL DRUGS[J]. VALUE IN HEALTH, 2019, 22(2), S175-S175.
Authors:  Lai, YF;  Chen, SQ;  Chen, PH;  Chen, XW;  Ung, COL; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.9/5.6 | Submit date:2020/03/13
EFFECT AND COST OF TRADITIONAL CHINESE MEDICINE XIYANPING INJECTION FOR TREATING COMMUNITY ACQUIRED PNEUMONIA AMONG ADULTS IN CHINA Journal article
Shi, H, Guo, WJ, Zhu, H, Li, M, Ung, COL, Hu, H, Han, S. EFFECT AND COST OF TRADITIONAL CHINESE MEDICINE XIYANPING INJECTION FOR TREATING COMMUNITY ACQUIRED PNEUMONIA AMONG ADULTS IN CHINA[J]. VALUE IN HEALTH, 2019, 22(2), S361-S362.
Authors:  Shi, H;  Guo, WJ;  Zhu, H;  Li, M;  Ung, COL; et al.
Favorite | TC[WOS]:1 TC[Scopus]:0  IF:4.9/5.6 | Submit date:2020/03/13
PRS31 The economic impact of optimized post-hospitalization management for an exacerbation in COPD patients in China Conference paper
Salem, A., Ramos, M., Hu, H., Zhong, H., Lamotte, M.. PRS31 The economic impact of optimized post-hospitalization management for an exacerbation in COPD patients in China[C], 2018, S409-S409.
Authors:  Salem, A.;  Ramos, M.;  Hu, H.;  Zhong, H.;  Lamotte, M.
Favorite |  | Submit date:2022/07/27
COPD  China